Serialization Software Blog

An important part of the implementation process when deploying a serialization project is being able to easily connect with your trading partners. Unfortunately, when there are connection challenges, you can experience higher costs, low reliability and slower implementations. We noticed that many in the pharma...

At one time, Ian Miller, Verify Brand’s pharma serialization sales director, thought his master’s degree in diplomacy would be a springboard to a career representing the United Sates among international organizations. Instead, he followed a different avenue and now acts as Verify Brand’s ambassador to...

Covis Pharma, a global biotech company based in Switzerland, has selected Verify Brand as its serialization software provider to meet the FDA’s November 2017 DSCSA deadline. Covis Pharma is a specialty manufacturer of several therapeutic solutions for patients with life-threatening conditions and chronic illnesses, ranging...

Pharmaceutical serialization is a complicated subject. While pharma companies around the world are trying to grasp the business impacts of serialization and assemble their teams to meet U.S. and global regulatory compliance mandates, Verify Brand has been educating the industry about the importance of doing...

Last Friday, June 30, the FDA announced that it will push back enforcement of the Drug Supply Chain Security Act (DSCSA) product identification mandate to November 2018. You can download the FDA’s guidance for the pharmaceutical industry here; meanwhile, we have a few key points...

During the past several months, Verify Brand has been growing by leaps and bounds as pharma organizations are choosing our serialization software to help them successfully meet regulatory compliance mandates in the U.S. (DSCSA) and the EU (FMD). To ensure that we flawlessly deliver our SWIFT implementation framework...

The Verify Brand serialization experts were in Lisbon, Portugal last week where we presented at the Pharma CMO Summit organized by Supply Chain Wizard. With the EU FMD less than two years away, this event invited pharma manufactures, CMOs, CPOs 3PLs and solution providers to...

Thanks to our standards-based software, we’re fully connected to all your trading partners, and we don’t charge extra fees to connect. If you’re in the pharmaceutical industry and need to comply with government regulations, you’re probably aware that wherever your organization sits in the supply chain,...

Don't sacrifice long-term ROI. Be sure you're getting business-transforming insights beyond compliance. With the Drug Supply Chain Security Act (DSCSA) November 2017 deadline in a few months and the EU’s Falsified Medicines Directives (FMD) taking effect in less than two years, pharma manufacturers, CMOs/CPOs and 3PLS are...

Translate »